• New Drugs Approved
    • 2024 Approvals
    • 2023 Approvals
  • Health and Medical Research News
    • Arthritis
    • Bronchitis
    • Cancer
    • Diabetes
    • Eye
    • Heart Conditions
    • Vaccines and Infections
    • Mental Health
    • Neurology
    • Pain Conditions
    • Skin Conditions
    • Stomach & Intestine
FDA Approves Dupixent for Children Suffering from Eosinophilic Esophagitis on January 2024

FDA Approves Dupixent for Children Suffering from Eosinophilic Esophagitis on January 2024

by B Jamerson | Jul 22, 2024 | 2024 Approvals, Drug approvals, New Drugs Approved

What is Dupixent prescribed for? DUPIXENT (generic name: dupilumab), pronounced DU-pix-ent is prescribed for children aged 1 year and older to treat eosinophilic esophagitis (EoE), a chronic inflammatory condition of the esophagus. EoE is caused by a buildup of...
FDA Approves Amtagvi for Advanced Skin Cancer on February 16, 2024

FDA Approves Amtagvi for Advanced Skin Cancer on February 16, 2024

by B Jamerson | Jul 22, 2024 | 2024 Approvals, Drug approvals, New Drugs Approved

What is Amtagvi prescribed for?   Amtagvi is prescribed to treat adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor....
FDA Expands Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy: June 2023

FDA Expands Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy: June 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals, New Drugs Approved

What is Elevidys prescribed for?   To treat Duchenne muscular dystrophy (DMD) in patients who are 4 years of age and older and have a confirmed mutation in the DMD gene. What is the name of the drug and what does it do?  Elevidys (generic name:...
FDA Approves BRENZAVVY for Type 2 Diabetes Management on January 20, 2023

FDA Approves BRENZAVVY for Type 2 Diabetes Management on January 20, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals

What is BRENZAVVY prescribed for?   BRENZAVVY is prescribed to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise. What is the name of the drug and what does it do? BRENZAVVY, pronounced bren-ZA-vee, (generic...
FDA Approves Xolair for Food Allergy Management on February 16, 2024

FDA Approves Xolair for Food Allergy Management on February 16, 2024

by B Jamerson | Jul 22, 2024 | 2024 Approvals, Drug approvals, New Drugs Approved

What is Xolair prescribed for?   Xolair is prescribed to treat food allergy in people 1 year of age and older to reduce allergic reactions that may occur after accidentally eating one or more foods to which you are allergic. What is the name of the drug and...
Page 20 of 22« First«...10...1819202122»

Latest Posts

  • Research Progress for Chronic Bronchitis: Sulforaphane Strengthens Lung Defenses
  • Do All Men with Prostate Cancer Get the Same Treatment? A Look at Racial and Ethnic Gaps
  • New Light on Osteoarthritis: Innovative Imaging Techniques Unveil Early Joint Damage
  • New Combination Therapy Shows Promise for Advanced Urinary Tract Cancer
  • New Discovery Could Lead to Better Treatments for Rheumatoid Arthritis

ScienceMyHealth is a product of iSimcha.

Navigate

HomePage

Blog

 

Company

About Us

Contact Us

© 2025 iSimcha

Privacy Policy

Terms of Service